NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
79 hedge funds and large institutions have $84.4M invested in Navidea Biopharmaceuticals Inc. in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
-3
Holders Change %
-3.66%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
27
Reduced
17
Closed
9
Calls
$368K
Puts
$9.93M
Net Calls
-$9.57M
Net Calls Change
-$103K
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$6.77M |
| 2 |
PM
2
Platinum Management
New York
|
$19.6M |
| 3 |
3
HighTower Advisors
Chicago,
Illinois
|
$752K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$3.09M |
| 5 |
5
New York State Common Retirement Fund
Albany,
New York
|
$297K |
